Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer

675.05
4.46%
Anand Rathi
We expect it is likely to deliver 18%/22%/25% revenue/EBITDA/PAT CAGRs over FY25-27 due to swelling demand, capacity expansion and mounting exports.
Number of FII/FPI investors decreased from 82 to 65 in Jun 2025 qtr
More from Rossari Biotech Ltd.
Recommended